1. Home
  2. TRI vs ZTS Comparison

TRI vs ZTS Comparison

Compare TRI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thomson Reuters Corp

TRI

Thomson Reuters Corp

HOLD

Current Price

$95.22

Market Cap

44.2B

Sector

N/A

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$112.66

Market Cap

49.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRI
ZTS
Founded
1851
1952
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.2B
49.7B
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
TRI
ZTS
Price
$95.22
$112.66
Analyst Decision
Buy
Buy
Analyst Count
12
12
Target Price
$154.58
$154.18
AVG Volume (30 Days)
1.5M
2.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.62%
1.86%
EPS Growth
N/A
10.05
EPS
N/A
6.02
Revenue
N/A
$9,467,000,000.00
Revenue This Year
$8.90
$5.63
Revenue Next Year
$7.89
$4.77
P/E Ratio
$25.72
$18.71
Revenue Growth
N/A
2.28
52 Week Low
$79.71
$112.10
52 Week High
$218.40
$172.23

Technical Indicators

Market Signals
Indicator
TRI
ZTS
Relative Strength Index (RSI) 55.91 37.99
Support Level $86.48 N/A
Resistance Level $98.22 $129.28
Average True Range (ATR) 4.19 2.79
MACD 0.76 -0.58
Stochastic Oscillator 50.90 11.93

Price Performance

Historical Comparison
TRI
ZTS

About TRI Thomson Reuters Corp

Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: